SCHEMBL4189868

SCHEMBL4189868

C[C@@H](CC1CCCCC1)NCc1ccccc1NC(=O)c1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDLR P01130 2/20 0.46
KDM4E B2RXH2 1/20 0.43
HDAC1 Q13547 5/20 0.42
HDAC3 O15379 2/20 0.42
HDAC2 Q92769 2/20 0.42
GAA P10253 1/20 0.42
DRD1 P21728 1/20 0.41
HRH2 P25021 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
OPRK1 P41145 1/20 0.41
HTR2B P41595 1/20 0.41
KCNH2 Q12809 1/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
F2RL1 P55085 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193519 0.90 MEN1 (0.47) KDM4EHDAC1HDAC3HDAC2GAA
SCHEMBL4184490 0.90 MEN1 (0.47) KDM4EHDAC1HDAC3HDAC2GAA
SCHEMBL4186045 0.88 MEN1 (0.48) KDM4EDRD1HRH2HTR2AHTR2C
SCHEMBL4198225 0.88 CTSL (0.44) LDLRKDM4EGAADRD1HRH2
SCHEMBL4190624 0.88 CTSL (0.44) LDLRKDM4EGAADRD1HRH2
SCHEMBL4197332 0.88 CTSL (0.44) LDLRKDM4EGAADRD1HRH2
SCHEMBL4192323 0.86 KMT2A (0.44) KDM4EHDAC1GAADRD1HRH2
SCHEMBL4186006 0.86 KMT2A (0.44) KDM4EHDAC1GAADRD1HRH2
SCHEMBL4195135 0.86 MAPT (0.47) KDM4EHDAC1KMT2AMEN1LMNA
SCHEMBL4192548 0.83 KMT2A (0.47) KDM4EKMT2AMEN1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 LDLR 4545/4885KDM4E 3328/4885HDAC1 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.